Cargando…
Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
Oncogenic neurotrophic tropomyosin receptor kinase gene fusions occur in less than 1% of common cancers. These mutations have emerged as new biomarkers in cancer genomic profiling with the approval of selective drugs against tropomyosin receptor kinase fusion proteins. Nevertheless, the optimal path...
Autores principales: | Petaccia de Macedo, Mariana, Toledo Nascimento, Ellen Caroline, Soares, Fernando Augusto, Costa Santini, Fernando, D’Almeida Costa, Felipe, Werneck da Cunha, Isabela, Ramella Munhoz, Rodrigo, De Marchi, Pedro, Carnier Jorge, Thiago William, Ramos Moreira Leite, Kátia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504829/ https://www.ncbi.nlm.nih.gov/pubmed/37719804 http://dx.doi.org/10.1177/2632010X231197080 |
Ejemplares similares
-
Expert consensus on the diagnosis and treatment of
NTRK
gene fusion solid tumors in China
por: Xu, Chunwei, et al.
Publicado: (2022) -
Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours
por: Garrido, P., et al.
Publicado: (2021) -
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome
por: Sandoval, Renata Lazari, et al.
Publicado: (2021) -
Clinical management and diagnosis of CLN2 disease: consensus of the Brazilian experts group
por: Sampaio, Leticia Pereira de Brito, et al.
Publicado: (2023) -
Brazilian experts' consensus on the treatment of infantile epileptic spasm syndrome in infants
por: Sampaio, Letícia Pereira de Brito, et al.
Publicado: (2023)